Showing results (1291-1300 of 6,752) with videos related to
Sort By:
Pageof 676
European Journal of Neurology|March 13, 2026
Who Can Safely Discontinue Treatment in Myasthenia Gravis? Insights From a Long-Term Real-World StudyDingxian He, Chong Yan, Baitong Wang, et al.European Journal of Neurology|March 6, 2026
Long-Term Outcomes and Natural Course of Giant Cerebral Arteriovenous Malformations (> 6 cm): Insights From a National Multicenter Propensity Score-Matched CohortNan Li, Yukun Zhang, Chengzhuo Wang, et al.European Journal of Neurology|December 18, 2008
Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon-βD Hesse, J L Frederiksen, N Koch-Henriksen, et al.European Journal of Neurology|November 29, 2013
Transcranial Doppler monitoring of cerebral embolism in atrial fibrillation and prosthetic valves. Clinical correlationsG P Anzola, A Costa, M Magoni, et al.European Journal of Neurology|August 2, 2005
EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task forceG Bråthen, E Ben-Menachem, E Brodtkorb, et al.European Journal of Neurology|December 22, 2016
Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial studyL H Markvardsen, S H Sindrup, I Christiansen, et al.European Journal of Neurology|December 22, 2016
People with epilepsy receive more statins than the general population but have no higher cardiovascular risk: results from a cross-sectional studyR M Vivanco-Hidalgo, R Elosua, A Gómez González, et al.European Journal of Neurology|December 22, 2016
The role of objective cognitive dysfunction in subjective cognitive complaints after strokeM W A van Rijsbergen, R E Mark, W J Kop, et al.European Journal of Neurology|November 2, 2016
Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progressionM Moccia, M Quarantelli, R Lanzillo, et al.Pageof 676